Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Veolia Environnement SA | VVD | Nov 26, 2024 | 27.71 | -0.61 |
Vera Bradley, Inc. | ELI | Nov 26, 2024 | 5.30 | +7.29 |
Veracyte, Inc. | 12V | Nov 26, 2024 | 39.20 | +3.16 |
VERALLIA. | 1VRA | Nov 26, 2024 | 25.42 | -2.46 |
Veralto | RZ2 | Nov 26, 2024 | 104.02 | +3.03 |
VERANO HOLDINGS (SUB.VT.) | 76U0 | Nov 26, 2024 | 2.86 | 0.00 |
Verastem | 2VSA | Nov 26, 2024 | 3.68 | -3.66 |
Verbio SE | VBK | Nov 26, 2024 | 11.28 | +1.17 |
Verbrec Limited | 47L | Nov 26, 2024 | 0.06 | -6.11 |
Verbund AG | OEWA | Nov 26, 2024 | 75.35 | -1.12 |
Verbund AG | OEW | Nov 26, 2024 | 15.00 | +0.67 |
Vercom S.A. | 14W | Nov 26, 2024 | 26.30 | -0.75 |
Veren | 0160 | Nov 26, 2024 | 5.00 | -0.99 |
Vergnet | VRQ | Nov 26, 2024 | 0.00 | 0.00 |
Verianos Real Estate AG | VROS | Nov 26, 2024 | 0.00 | 0.00 |
Vericel Corporation | ATQP | Nov 26, 2024 | 55.50 | -1.77 |
Verici Dx Plc | 63V | Nov 26, 2024 | 0.04 | 0.00 |
VerifyMe, Inc. | LT1B | Nov 26, 2024 | 0.59 | +1.72 |
Verimatrix | I3Q | Nov 26, 2024 | 0.30 | +4.56 |
Verint Systems Inc. | VTY | Nov 26, 2024 | 23.00 | -0.86 |
VeriSign, Inc. | VRS | Nov 26, 2024 | 172.50 | +1.26 |
Verisk Analytics, Inc. | VA7A | Nov 26, 2024 | 277.70 | 0.00 |
Veritex Holdings, Inc. | 47Y | Nov 26, 2024 | 29.00 | +4.32 |
Veritone, Inc. | VEK | Nov 26, 2024 | 2.60 | -0.69 |
VERIZON COMMUNICAT. CDR | BACB | Nov 26, 2024 | 12.80 | +1.59 |
Verizon Communications Inc. | BAC | Nov 26, 2024 | 42.22 | +1.27 |
Verkkokauppa.com | 15V | Nov 26, 2024 | 1.39 | -0.71 |
Vermilion Energy Inc. Common (Canada) | CVZ | Nov 26, 2024 | 9.89 | -1.65 |
Verona Pharma plc - American Depositary Shares | I9SA | Nov 26, 2024 | 36.60 | -1.61 |
Verra Mobility Corp | 0YK | Nov 26, 2024 | 22.80 | +0.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.